Page 10 - Trial Data News Today

Im john berman with brianna keilar. it is monday, september 20th. the breaking news this morning comes in the fight against covid-19, this morning just a short time ago, pfizer released its first data on its vaccines for children as young as 5. the company says, now this is data coming from the company, it has not been peer reviewed, the company says the coronavirus vaccine is safe for that group and it shows a robust antibody response. >> now this is a trial that included participants ages 5 to...

Good monday morning. im erica hill. >> and im jim sciutto. breaking this morning, its good news. new and critical data in the race to vaccinate children. pfizer reports that its vaccine is safe for young children, those under the age of 12, saying trial data shows a robust and well-tolerated response in 5 to 11-year-olds. the company adding it expects data on children as young as 6 months old before the end of the year as well. well have more on that in just a moment. also developing this morn...

In the gulf tonight. ginger, thank you. the other there will be boosters for adults in the u.s. the uk planning to give boosters to those 50 and older to prepare for the winter ahead. heres stephanie ramos. >> reporter: for millions of parents eager to know how soon their younger children could finally get a vaccine, tonight, a clearer picture. pfizer today revealing it will submit data from its trial for 5 to 11-year-olds to the fda in early october. followed by trial data for children 6 mont...

Put in mask mandates. that coupled with how they mitigate the spread will affect the number of outbreaks we see in schools according to the health experts. which gets me to the next thing well be looking for in the coming months. when kids under 12 will be able to get the vaccine. trial data is still being gathered. once thats done it will be submitted to the fda. pfizer thinks it will be able to hand in this information by september, and then file for emergency use authorization by october. acc...

And of course the goal is to get as many back in the classroom while keeping the covid cases town. delta variant is still dominating and we know that there are vastly different rules governing school districts. so that is why health experts health experts to exceed the goal stick to the science. whatre seeing is a mixed bag of mask adherence, some requiring masks, others not, others making laws against, and others only making it mandatory for the unvacci unvaccinated. one thing is for sure this ...

One doctor was forced to make an agonizing decision. >> im a third generation oncologist. the one principle that my family had built is that we would never turn away a patient regardless of whether they could pay or not and for the first time in 60 years of my familys history of treating cancer, we had to turn someone away because we didnt have a bed. there was simply no room in the hospital to treat the patient. what were seeing is a tremendous amount of patients coming in, the other day our em...

Contributor and former white house of policy, doctor, welcome, good to see you again. >> you too joshua. >> lets begin with a question from virginal, i just got a third vaccine because of being immunocompromised, how long will it take for the extra protection to kick in, is it two weeks like the first shot, or sooner? doctor? >> virginal, its a good question, we have seen immunity in a response as early as one week after the third shot. which is great news, dont rush off to get a test for this w...

Vaccines and boosters so lets get you more answers in tonights installment of "dear doctor." >> good to see you again? >> virgil asks, i just got a third vaccine because of being imuno compromised. how long will it take to kick in? doctor? >> yeah, virgil thats a perfect question. we have seen immunity as early as one week after the third shot, but dont rush out to get a test for this because we are still working through whether those tests mean anything, and a lot of trial data got us to recomm...

/PRNewswire/ -- The "Drug Discovery Informatics Market Share, Size, Trends, Industry Analysis Report, By Workflow; By Mode; By Services; By Regions; Segment...

That it can stop disease from spreading is very close tonight. and another poster? lets see what that trial data says, i just dont believe in natural immunity that many, many people have. i would guess 100 million people in the united states are recovering from the disease provides the same against the disease as the vaccine does. the natural immunity seems to be fairly long-lasting as dr. risch said. i just understand why you would jump ahead and say you need a booster in place to anything like...